![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 08, 2022 5:24:48 PM
Jack this says it all, science backed and patented and toss the word FDA in and the retailers will be all over this. This has sales and money written all over it.
Enzolytics IPF Immune™, a science-backed patented immune modulator, will debut at ECRM’s Weight Management, Nutrition, and Vitamin Program in March.
"Enzolytics IPF Immune™ is the supplement for the post-pandemic era,” said Charles S. Cotropia, CEO of Enzolytics, Inc., which is based in Texas. "Immunity booster supplements have become very popular because of COVID-19, and we believe consumers will choose our supplement because our immune modulator helps fortify the immune system against infections.”
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM